HPLC
IndustriesPharma & Biopharma
ManufacturerAgilent Technologies
Význam tématu
Transferring USP compendial gradient methods from conventional HPLC to UHPLC under chapter 621 guidelines offers significant gains in throughput, solvent savings and cost efficiency. Enabling column dimension, particle size and flow adjustments within defined limits supports faster, greener and more economical quality control analyses in pharmaceutical laboratories.
Cíle a přehled studie / článku
This application note describes the conversion of the USP monograph method for assessing organic impurities in acetaminophen from a legacy HPLC system to UHPLC conditions using Agilent 1260 Infinity II Prime LC. The goals are to demonstrate compliance with USP 621 adjustment rules, quantify reductions in runtime and solvent usage, and evaluate the impact on cost per injection with a built-in savings calculator.
Použitá metodika a instrumentace
The study relies on the USP 621 permitted adjustments for gradient elution: maintaining L/dp ratio within –25 % to +50 %, scaling flow rate, injection volume and gradient time by standard equations, and ±5 °C temperature variation. Instrumentation included:
- Legacy Agilent 1100 Series: degasser G1322A, quaternary pump G1311A, autosampler G1313A, column compartment G1316A, DAD G1315B
- Agilent 1260 Infinity II Prime LC: flexible pump G7104C, vialsampler G7129C, multicolumn thermostat G7116A, DAD HS G7117C with Max-Light cell
- Software: Agilent OpenLab CDS 2.6
- Columns: ZORBAX Eclipse Plus C8 (4.6×250 mm, 5 µm), Poroshell 120 EC-C8 (4.6×150 mm, 2.7 µm and 2.1×150 mm, 2.7 µm)
- Mobile phases A: methanol : water : acetic acid 50 : 950 : 1; B: methanol : water : acetic acid 500 : 500 : 1
- Standards of acetaminophen and related impurity compounds in methanol
Hlavní výsledky a diskuse
System suitability and impurity separations met tailing, resolution and precision criteria for all configurations. Transferring from 4.6×250 mm, 5 µm to 4.6×150 mm, 2.7 µm reduced run time by 67.6 % and solvent use by 39.9 %. Further shrinking to 2.1×150 mm, 2.7 µm maintained the same 23.65 min cycle while cutting solvent consumption by 87.4 %. L/dp increased by 11 %, remaining within USP limits.
Přínosy a praktické využití metody
Implementing UHPLC conditions under USP 621:
- Slashes cost per injection via shorter runs and lower solvent volumes
- Boosts laboratory throughput and productivity
- Reduces waste disposal and environmental footprint
- Leverages a cost-savings calculator to model instrument replacement and ROI
Budoucí trendy a možnosti využití
Further applications may include method transfers for other compendial assays, adoption of superficially porous and sub-2 µm columns, integration with predictive software tools, and expanded green chromatography approaches. Real-time optimization of temperature and pressure and miniaturized flow paths promise additional efficiency gains.
Závěr
The transfer of the acetaminophen impurity method from a legacy HPLC to the Agilent 1260 Infinity II Prime UHPLC system under USP chapter 621 guidelines delivers dramatic reductions in analysis time and solvent requirements while preserving separation performance. Cost modelling indicates payback within approximately 2 years based on typical laboratory workloads.
Reference
- United States Pharmacopeial Convention. General Chapter 621 Chromatography. USP–NF, December 2022.
- United States Pharmacopeial Convention. Monograph for Acetaminophen. USP–NF, January 2023.
Content was automatically generated from an orignal PDF document using AI and may contain inaccuracies.